Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

30
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
30
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

43
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
43
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

49
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
49
Complement System01:27

Complement System

2.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.5K
Overview
69.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

40
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis Associated With a Novel CFHR5 Copy Number Variant.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation".

Kidney international reports·2026
Same author

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis.

Frontiers in immunology·2026
Same author

Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays.

Kidney international reports·2026
Same author

C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients.

Frontiers in immunology·2025
Same author

Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic Microangiopathy.

Kidney international reports·2024

Related Experiment Video

Updated: Aug 7, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.8K

The Complement System in Kidney Transplantation.

Donata Santarsiero1, Sistiana Aiello1

  • 1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.

Cells
|March 11, 2023
PubMed
Summary
This summary is machine-generated.

The complement system significantly impacts kidney transplant outcomes. Novel therapies targeting this system show promise for improving graft survival by reducing injury and rejection.

Keywords:
alloresponseantibody-mediated rejectioncomplement activationcomplement therapeuticsdelayed graft functionischaemia/reperfusion injurykidney transplantation

More Related Videos

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Related Experiment Videos

Last Updated: Aug 7, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.8K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Area of Science:

  • Immunology
  • Transplantation Science
  • Nephrology

Background:

  • Kidney transplantation is the preferred treatment for end-stage renal disease.
  • Long-term graft survival remains a challenge despite advancements in surgical and immunosuppressive strategies.
  • The complement cascade, a key innate immune component, contributes to inflammatory responses and graft damage during transplantation.

Purpose of the Study:

  • To explore the role of the complement system in kidney transplantation.
  • To discuss emerging complement inhibitory therapies for improving transplant outcomes.
  • To highlight the potential of these therapies in mitigating ischemia/reperfusion injury and antibody-mediated rejection.

Main Methods:

  • Review of existing literature on complement activation in transplantation.
  • Analysis of the impact of complement on cellular and humoral immune responses to allografts.
  • Discussion of novel complement inhibitory drugs and their mechanisms of action.

Main Results:

  • The complement system critically influences inflammatory reactions, including ischemia/reperfusion injury.
  • Complement activation modulates T and B cell responses to alloantigens, contributing to graft damage.
  • Emerging complement inhibitors offer potential therapeutic avenues.

Conclusions:

  • Targeting the complement cascade presents a promising strategy to enhance kidney transplant success.
  • Complement inhibition can ameliorate ischemia/reperfusion injury and modulate adaptive immune responses.
  • Novel therapies may prove effective in treating antibody-mediated rejection and improving long-term graft survival.